These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15078136)

  • 1. Ex-vivo uses and applications of cytokines for adoptive immunotherapy in cancer.
    Foster AE; Forrester K; Li YC; Gottlieb DJ
    Curr Pharm Des; 2004; 10(11):1207-20. PubMed ID: 15078136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of fully activated dendritic cells capable of priming tumor-specific cytotoxic T lymphocytes in patients with metastatic cancer using penicillin-killed streptococcus pyogenes (OK432) and anti-CD40 antibody.
    Kontani K; Teramoto K; Ozaki Y; Sawai S; Tezuka N; Ishida H; Kajino K; Fujino S; Yamauchi A; Taguchi O; Kannagi R; Yokomise H; Ogasawara K
    Oncol Rep; 2007 Apr; 17(4):895-902. PubMed ID: 17342333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo expansion of hematopoietic cells and their clinical use.
    Aglietta M; Bertolini F; Carlo-Stella C; De Vincentiis A; Lanata L; Lemoli RM; Olivieri A; Siena S; Zanon P; Tura S
    Haematologica; 1998 Sep; 83(9):824-48. PubMed ID: 9825579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface-Engineering of Red Blood Cells as Artificial Antigen Presenting Cells Promising for Cancer Immunotherapy.
    Sun X; Han X; Xu L; Gao M; Xu J; Yang R; Liu Z
    Small; 2017 Oct; 13(40):. PubMed ID: 28861943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cells and immunotherapy for malignant disease.
    Reid DC
    Br J Haematol; 2001 Mar; 112(4):874-87. PubMed ID: 11298582
    [No Abstract]   [Full Text] [Related]  

  • 6. Improvement of adoptive cellular immunotherapy of human cancer using ex-vivo gene transfer.
    Paul S; Calmels B; Acres RB
    Curr Gene Ther; 2002 Feb; 2(1):91-100. PubMed ID: 12108977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cells in cancer immunotherapy.
    Gunzer M; Grabbe S
    Crit Rev Immunol; 2001; 21(1-3):133-45. PubMed ID: 11642600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Programmed Death-Ligand 1 on Antigen-presenting Cells Facilitates the Induction of Antigen-specific Cytotoxic T Lymphocytes: Application to Adoptive T-Cell Immunotherapy.
    Goto T; Nishida T; Takagi E; Miyao K; Koyama D; Sakemura R; Hanajiri R; Watanabe K; Imahashi N; Terakura S; Murata M; Kiyoi H
    J Immunother; 2016 Oct; 39(8):306-15. PubMed ID: 27548033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial antigen-presenting cells expressing AFP(158-166) peptide and interleukin-15 activate AFP-specific cytotoxic T lymphocytes.
    Sun L; Guo H; Jiang R; Lu L; Liu T; Zhang Z; He X
    Oncotarget; 2016 Apr; 7(14):17579-90. PubMed ID: 27007051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antitumor immunity and cellular cancer therapies].
    Catros-Quemener V; Bouet F; Genetet N
    Med Sci (Paris); 2003 Jan; 19(1):43-53. PubMed ID: 12836191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploiting cytokines in adoptive T-cell therapy of cancer.
    Petrozziello E; Sturmheit T; Mondino A
    Immunotherapy; 2015; 7(5):573-84. PubMed ID: 26065481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy with dendritic cells for cancer.
    Ballestrero A; Boy D; Moran E; Cirmena G; Brossart P; Nencioni A
    Adv Drug Deliv Rev; 2008 Jan; 60(2):173-83. PubMed ID: 17977615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expansion of HER2/neu-specific T cells ex vivo following immunization with a HER2/neu peptide-based vaccine.
    Knutson KL; Disis ML
    Clin Breast Cancer; 2001 Apr; 2(1):73-9. PubMed ID: 11899386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adoptive immunotherapy: good habits instilled at youth have long-term benefits.
    Paulos CM; Suhoski MM; Plesa G; Jiang T; Basu S; Golovina TN; Jiang S; Aqui NA; Powell DJ; Levine BL; Carroll RG; Riley JL; June CH
    Immunol Res; 2008; 42(1-3):182-96. PubMed ID: 18949448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.
    Zitvogel L; Mayordomo JI; Tjandrawan T; DeLeo AB; Clarke MR; Lotze MT; Storkus WJ
    J Exp Med; 1996 Jan; 183(1):87-97. PubMed ID: 8551248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospects for personalized combination immunotherapy for solid tumors based on adoptive cell therapies and immune checkpoint blockade therapies.
    Kato D; Yaguchi T; Iwata T; Morii K; Nakagawa T; Nishimura R; Kawakami Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(1):68-77. PubMed ID: 28539557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
    da Cunha A; Antoniazi Michelin M; Cândido Murta EF
    Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trials with immunotherapy for high-grade glioma.
    Ruzevick J; Jackson C; Phallen J; Lim M
    Neurosurg Clin N Am; 2012 Jul; 23(3):459-70. PubMed ID: 22748658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adoptive cellular therapy of malignancy.
    Chang AE; Geiger JD; Sondak VK; Shu S
    Arch Surg; 1993 Nov; 128(11):1281-90. PubMed ID: 8239992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cancer treatment by comprehensive regulation of anti-tumor immune network].
    Kawakami Y
    Nihon Rinsho; 2010 Jun; 68(6):1094-9. PubMed ID: 20535961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.